Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
Robert M
RM
Califf
D000925:Anticoagulants / Q000627:therapeutic use*; D005170:Factor X / Q000037:antagonists & inhibitors; D000077425:Fondaparinux; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011134:Polysaccharides / Q000627:therapeutic use*
D000925:Anticoagulants; D011134:Polysaccharides; D005170:Factor X; D000077425:Fondaparinux